Skip to main content
Clinical Trials/ACTRN12617001001381
ACTRN12617001001381
Completed
未知

Randomised Controlled Trial on the effect of lifestyle intervention enabled by mobile technologies versus standard treatment to facilitate weight loss in patients with Non-alcoholic Fatty Liver Disease

im Su Lin0 sites108 target enrollmentJuly 11, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
on-Alcoholic Fatty Liver Disease
Sponsor
im Su Lin
Enrollment
108
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 11, 2017
End Date
November 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
im Su Lin

Eligibility Criteria

Inclusion Criteria

  • The study is conducted in Singapore, at National University Hospital.
  • The inclusion criteria includes:
  • \- Adult patients adults above 21\-70 years old who have been diagnosed with NAFLD, confirmed by the presence of steatosis in the liver on ultrasound.
  • \- Have BMI greater and equal to 23 kg/m2
  • \- Own a smart\-phone with data plan
  • \- English\-speaking
  • \- Willing to consent to the study

Exclusion Criteria

  • Patients will be excluded if they meet the following criteria:
  • \- Consumption of more than 1\.5 times the limit of alcohol recommended for the population (alcohol dose 15 g/week for women and 30 g/week for men)
  • \- no serologic evidence of previous hepatitis B or C infection, chronic liver disease or cirrhosis or concomitant liver diseases
  • \- pregnant
  • \- on hepatotoxic medication
  • \- poorly controlled diabetes mellitus (HbA1c \> 10%), diabetes needing insulin,
  • \- recent cardiovascular event in the past 6 months, known heart failure
  • \- stage 4 and above kidney disease
  • \- untreated hypothyroidism, depression
  • \- mentally challenged

Outcomes

Primary Outcomes

Not specified

Similar Trials